Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways
Oncology Reports · 12.03.2026 · 55 (5) · 1-14
DOI: 10.3892/or.2026.9099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 12.03.2026. Verfasst von Ayaka Kunishima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Shinagawa, Tokyo 142‑8501, Japan. Hauptthemen laut MEDLINE: Osteosarcoma, Hypoxia-Inducible Factor 1, alpha Subunit, Bone Neoplasms. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Shinagawa, Tokyo 142‑8501, Japan.
- Department of Data Science, Oncology Innovation Center, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi 470‑1192, Japan.
- Department of Pharmacy, Japanese Red Cross Medical Center, Shibuya, Tokyo 150‑8935, Japan.
- Department of Gene Regulation, Oncology Innovation Center, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi 470‑1192, Japan.
- Department of Collaborative Research Resources (Laboratory Animal Center), Keio University School of Medicine, Shinjuku, Tokyo 160‑8582, Japan.
- Department of Environmental Health Sciences, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Shinagawa, Tokyo 142‑8501, Japan.
Zitieren
APA
Kunishima, A., Shimizu, T., Takimoto, T., Sagara, A., Nobusue, H., Hasuwa, H., Hasegawa, S., Tamaoki, Y., Miyake, H., Fukuchi, Y., Saya, H., & Muto, A. (2026). Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways. Oncology Reports, 55(5), 1-14. https://doi.org/10.3892/or.2026.9099
Vancouver
Kunishima A, Shimizu T, Takimoto T, Sagara A, Nobusue H, Hasuwa H, et al. Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways. Oncology Reports. 2026;55(5):1-14. doi:10.3892/or.2026.9099
BibTeX
@article{Kunishima2026,
author = {Kunishima, Ayaka and Shimizu, Takatsune and Takimoto, Tetsuya and Sagara, Atsunobu and Nobusue, Hiroyuki and Hasuwa, Hidetoshi and Hasegawa, Shinya and Tamaoki, Yuka and Miyake, Hitomi and Fukuchi, Yumi and Saya, Hideyuki and Muto, Akihiro},
title = {Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways},
journal = {Oncology Reports},
year = {2026},
volume = {55},
number = {5},
pages = {1--14},
doi = {10.3892/or.2026.9099}
}
EUVIMED